Cargando…
Systematic profiling identifies PDLIM2 as a novel prognostic predictor for oesophageal squamous cell carcinoma (ESCC)
Till now, no appropriate biomarkers for high‐risk population screening and prognosis prediction have been identified for patients with oesophageal squamous cell carcinoma (ESCC). In this study, by the combined use of data from the Gene Expression Omnibus (GEO) datasets and The Cancer Genome Atlas (T...
Autores principales: | Song, Guiqin, Xu, Jun, He, Lang, Sun, Xiao, Xiong, Rong, Luo, Yuxi, Hu, Xin, Zhang, Ruolan, Yue, Qiuju, Liu, Kang, Feng, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653303/ https://www.ncbi.nlm.nih.gov/pubmed/31222932 http://dx.doi.org/10.1111/jcmm.14491 |
Ejemplares similares
-
SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain
por: Liu, Yanqun, et al.
Publicado: (2022) -
Combination of meta-analysis and graph clustering to identify prognostic markers of ESCC
por: Gao, Hongyun, et al.
Publicado: (2012) -
Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer
por: Hu, Xinpeng, et al.
Publicado: (2022) -
Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)
por: Wang, Jian, et al.
Publicado: (2021) -
Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic colorectal cancers
por: Oh, Bo Young, et al.
Publicado: (2017)